Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SRI-29329 is a potent, specific inhibitor of CDC-like kinase (with IC50 of 78 nM, 16 nM and 86 nM for CLK1, CLK2 and CLK4, respectively).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 84.00 | |
5 mg | In stock | $ 198.00 | |
10 mg | In stock | $ 323.00 | |
25 mg | In stock | $ 547.00 | |
50 mg | In stock | $ 788.00 | |
100 mg | In stock | $ 1,080.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 226.00 |
Description | SRI-29329 is a potent, specific inhibitor of CDC-like kinase (with IC50 of 78 nM, 16 nM and 86 nM for CLK1, CLK2 and CLK4, respectively). |
Targets&IC50 | CLK1:78 nM , CLK2:16 nM , CLK4:86 nM |
Molecular Weight | 399.92 |
Formula | C20H26ClN7 |
CAS No. | 2086809-58-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 32.5 mg/mL (81.26 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SRI-29329 2086809-58-5 Cell Cycle/Checkpoint CDK SRI 29329 Cyclin dependent kinase inhibit SRI29329 Inhibitor inhibitor